Evan M Hersh

  • 19105 Citations
  • 67 h-Index
1965 …2021
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1965 2017

  • 19105 Citations
  • 67 h-Index
  • 490 Article
  • 48 Chapter
  • 3 Letter
  • 1 Conference contribution
Filter
Article
Article
1 Citation (Scopus)

Ability of cell-sized beads bearing tumor cell membrane proteins to stimulate LAK cells to secrete interferon-γ and tumor necrosis factor-α1

Chong, A. S. F., Pinkard, J. K., Lam, K. S., Scuderi, P., Hersh, E. M. & Grimes, W. J., Apr 15 1991, In : Cellular Immunology. 134, 1, p. 96-110 15 p.

Research output: Contribution to journalArticle

Lymphokine-Activated Killer Cells
Interferons
Membrane Proteins
Tumor Necrosis Factor-alpha
Neoplasms
20 Citations (Scopus)

Abnormal lymphocyte response to exogenous interleukin-2 in homosexuals with acquired immune deficiency syndrome (AIDS) and AIDS related complex (ARC)

Murray, J. L., Hersh, E. M., Reuben, J. M., Munn, C. G. & Mansell, P. W., 1985, In : Clinical and Experimental Immunology. 60, 1, p. 25-30 6 p.

Research output: Contribution to journalArticle

Interleukin-2
Acquired Immunodeficiency Syndrome
Lymphocytes
Prodromal Symptoms
Heterosexuality
4 Citations (Scopus)

Acquired immune deficiency syndrome: A new clinical entity

Hersh, E. M. & Mansell, P. W. A., Apr 1983, In : Clinical Immunology Newsletter. 4, 4, p. 39-43 5 p.

Research output: Contribution to journalArticle

Acquired Immunodeficiency Syndrome
7 Citations (Scopus)

Actinomycin-D plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamine (DTIC) with or without intravenous Corynebacterium parvum in metastatic malignant melanoma

Robidoux, A., Gutterman, J. U., Bodey, G. P. & Hersh, E. M., 1982, In : Cancer. 49, 11, p. 2246-2251 6 p.

Research output: Contribution to journalArticle

Propionibacterium acnes
Dactinomycin
Melanoma
Drug Therapy
Body Surface Area
28 Citations (Scopus)

Activation of cyclic nucleotide phosphodiesterase from isolated human peripheral blood lymphocytes by mitogenic agents

Epstein, P. M., Mills, J. S., Hersh, E. M., Strada, S. J. & Thompson, W. J., 1980, In : Cancer Research. 40, 2, p. 379-386 8 p.

Research output: Contribution to journalArticle

Cyclic Nucleotides
Phosphoric Diester Hydrolases
Phytohemagglutinins
Lymphocytes
Cyclic AMP
8 Citations (Scopus)

Activation of human lymphocyte high affinity cyclic AMP phosphodiesterase by culture with 1-methyl-3-isobutylxanthine

Thompson, W. J., Ross, C. P., Hersh, E. M., Epstein, P. M. & Strada, S. J., 1980, In : Journal of Cyclic Nucleotide Research. 6, 1, p. 25-36 12 p.

Research output: Contribution to journalArticle

1-Methyl-3-isobutylxanthine
Lymphocytes
Phosphoric Diester Hydrolases
Lymphocyte Activation
Cell culture
188 Citations (Scopus)

ACTIVE IMMUNOTHERAPY WITH B.C.G. FOR RECURRENT MALIGNANT MELANOMA

Gutterman, J. U., McBride, C., Freireich, E. J., Mavligit, G., Frei, E. & Hersh, E. M., Jun 2 1973, In : The Lancet. 301, 7814, p. 1208-1212 5 p.

Research output: Contribution to journalArticle

Active Immunotherapy
Mycobacterium bovis
Melanoma
Immunotherapy
Delayed Hypersensitivity
8 Citations (Scopus)

Active specific immunization with allogeneic leukemia associated antigens or irradiated allogeneic leukemia cells in acute leukemia

Ezaki, K., Hersh, E. M., Keating, M., Dyre, S., Hollinshead, A., McCredie, K. B., Mavlight, G. M. & Gutterman, J. U., 1978, In : Cancer. 41, 1, p. 70-83 14 p.

Research output: Contribution to journalArticle

Spontaneous Remission
Lymphoid Leukemia
Neoplasm Antigens
Lymphocyte Activation
Skin Tests
3 Citations (Scopus)

Acute leukemia in adults, 1977

Keating, M. J., Freireich, E. J., McCredie, K. B., Bodey, G. P., Hersh, E. M., Hester, J. P., Rodriguez, V. & Hart, J., 1977, In : CA Cancer Journal for Clinicians. 27, 1, p. 2-25 24 p.

Research output: Contribution to journalArticle

Acute Disease
Leukemia
43 Citations (Scopus)

Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED).

Buzdar, A. U., Blumenschein, G. R., Smith, T. L., Tashima, C. K., Hortobagyi, G. N., Yap, H. Y., Gutterman, J. U., Hersh, E. M. & Gehan, E. A., 1979, In : Journal of Surgical Oncology. 12, 1, p. 27-40 14 p.

Research output: Contribution to journalArticle

Mycobacterium bovis
Fluorouracil
Doxorubicin
Cyclophosphamide
Breast Neoplasms
58 Citations (Scopus)

Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette‐Guerin and with or without irradiation in operable breast cancer a prospective randomized trial

Buzdar, A. U., Blumenschein, G. R., Smith, T. L., Powell, K. C., Hortobagyi, G. N., Yap, H. Y., Schell, F. C., Barnes, B. C., Ames, F. C., Martin, R. G. & Hersh, E. M., 1984, In : Cancer. 53, 3, p. 384-389 6 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Fluorouracil
Doxorubicin
Cyclophosphamide
Bacillus
25 Citations (Scopus)

Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer (Dukes' class C). Prolongation of disease‐free interval and survival

Mavligit, G. M., Gutterman, J. U., Malahy, M. A., Burgess, M. A., McBride, C. M., Jubert, A. & Hersh, E. M., 1977, In : Cancer. 40, 5 S, p. 2726-2730 5 p.

Research output: Contribution to journalArticle

Mycobacterium bovis
Immunotherapy
Colorectal Neoplasms
Survival
Fluorouracil
21 Citations (Scopus)

Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer of the Dukes C classification. Preliminary clinical results

Mavligit, G. M., Gutterman, J. U., Burgess, M. A., Khankhanian, N., Seibert, G. B., Speer, J. F., Reed, R. C., Jubert, A. V., Martin, R. C., McBride, C. M., Copeland, E. M., Gehan, E. A. & Hersh, E. M., 1975, In : Cancer. 36, 6 sup., p. 2421-2427 7 p.

Research output: Contribution to journalArticle

Immunotherapy
Mycobacterium bovis
Colorectal Neoplasms
Fluorouracil
Recurrence
8 Citations (Scopus)

Administration of BCG cell wall skeleton into malignant effusions: Toxic and therapeutic effects

Richman, S. P., Hersh, E. M., Gutterman, J. U., Hortobagyi, G. N., Blumenschein, G. R., Rios, A. & Ribi, E., 1981, In : Cancer Treatment Reports. 65, 5-6, p. 383-387 5 p.

Research output: Contribution to journalArticle

Cell Wall Skeleton
Poisons
Therapeutic Uses
Mycobacterium bovis
Ascitic Fluid
30 Citations (Scopus)

Advances in the biological therapy and gene therapy of malignant disease

Hersh, E. M. & Stopeck, A. T., Dec 1997, In : Clinical Cancer Research. 3, 12 II, p. 2623-2629 7 p.

Research output: Contribution to journalArticle

Biological Therapy
Genetic Therapy
Neoplasms
HLA-B7 Antigen
Immune Evasion
87 Citations (Scopus)

A four-year experience with anthracycline, cytosine arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemia

Keating, M. J., Smith, T. L., McCredie, K. B., Bodey, G. P., Hersh, E. M., Gutterman, J. U., Gehan, E. & Freireich, E. J., 1981, In : Cancer. 47, 12, p. 2779-2788 10 p.

Research output: Contribution to journalArticle

Anthracyclines
Cytarabine
Vincristine
Prednisone
Combination Drug Therapy
30 Citations (Scopus)

A human monoclonal antimelanoma single-chain Fv antibody derived from tumor-infiltrating lymphocytes

Zhang, H., Lake, D. F., Barbuto, J. A. M., Bernstein, R. M., Grimes, W. J. & Hersh, E. M., 1995, In : Cancer Research. 55, 16, p. 3584-3591 8 p.

Research output: Contribution to journalArticle

Tumor-Infiltrating Lymphocytes
Single-Chain Antibodies
B-Lymphocytes
Melanoma
Polymerase Chain Reaction
6 Citations (Scopus)

A hybridoma producing human monoclonal antibody specific for glycoprotein 120kDa of human immunodeficiency virus (HIV-1)

Lake, D., Sugano, T., Matsumoto, Y. I., Masuho, Y., Petersen, E. A., Feorino, P. & Hersh, E. M., 1989, In : Life Sciences. 45, 16

Research output: Contribution to journalArticle

Hybridomas
Viruses
HIV-1
Glycoproteins
Monoclonal Antibodies
672 Citations (Scopus)

Alpha interferon for induction of remission in hairy-cell leukemia

Quesada, J. R., Reuben, J., Manning, J. T., Hersh, E. M. & Gutterman, J. U., 1984, In : New England Journal of Medicine. 310, 1, p. 15-18 4 p.

Research output: Contribution to journalArticle

Remission Induction
Hairy Cell Leukemia
Interferon-alpha
Agranulocytosis
Thrombocytopenia
23 Citations (Scopus)

Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced breast carcinoma

Blumenschein, G. R., Hortobagyi, G. N., Richman, S. P., Gutterman, J. U., Tashima, C. K., Buzdar, A. U., Burgess, M. A., Livingston, R. B. & Hersh, E. M., 1980, In : Cancer. 45, 4, p. 742-749 8 p.

Research output: Contribution to journalArticle

methanol extraction residue (MER) tubercle bacillus fraction
Active Immunotherapy
Mycobacterium bovis
Combination Drug Therapy
Breast Neoplasms
23 Citations (Scopus)

Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon

Lotzova, E., Savary, C. A., Quesada, J. R., Gutterman, J. U. & Hersh, E. M., 1983, In : Journal of the National Cancer Institute. 71, 5, p. 903-910 8 p.

Research output: Contribution to journalArticle

Natural Killer Cells
Interferons
Neoplasms
Injections
Phenotype
2 Citations (Scopus)

Analysis of the antitumor agent Bay i 7433 (copovithane) in plasma and urine by high performance liquid chromatography

Rosenblum, M. G., Hersh, E. M., Wingender, W. & Hersh, E. M., 1984, In : Journal of Liquid Chromatography. 7, 1, p. 159-166 8 p.

Research output: Contribution to journalArticle

High performance liquid chromatography
Antineoplastic Agents
High Pressure Liquid Chromatography
Urine
Plasmas
2 Citations (Scopus)

Anergy in cancer

Hersh, E. M., Gutterman, J. U. & Mavligit, G. M., 1976, In : International Journal of Dermatology. 15, 2, p. 112-120 9 p.

Research output: Contribution to journalArticle

Neoplasms
Intrinsic Factor
Neoplasm Antigens
Skin
Therapeutics
1579 Citations (Scopus)

A new type of synthetic peptide library for identifying ligand-binding activity

Lam, K. S., Salmon, S. E., Hersh, E. M., Hruby, V. J., Kazmierskit, W. M. & Knappt, R. J., Nov 7 1991, In : Nature. 354, 6348, p. 82-84 3 p.

Research output: Contribution to journalArticle

Peptide Library
Ligands
Libraries
Oligodeoxyribonucleotides
Cell Surface Receptors
29 Citations (Scopus)

An in vivo model of human multidrug-resistant multiple myeloma in SCID mice

Bellamy, W. T., Odeleye, A., Finley, P., Huizenga, B., Dalton, W. S., Weinstein, R. S., Hersh, E. M. & Grogan, T. M., Mar 1993, In : American Journal of Pathology. 142, 3, p. 691-698 8 p.

Research output: Contribution to journalArticle

SCID Mice
Multiple Myeloma
P-Glycoprotein
Heterografts
Doxorubicin
20 Citations (Scopus)

Antibodies to melanoma cell and BCG antigens in sera from tumour-free individuals and from melanoma patients

Minden, P., Jarrett, C., Mcclatchy, J. K., Gutterman, J. U. & Hersh, E. M., 1976, In : Nature. 263, 5580, p. 774-777 4 p.

Research output: Contribution to journalArticle

Mycobacterium bovis
Melanoma
Antigens
Antibodies
Mycobacterium
85 Citations (Scopus)

Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro

Robinson, W. E., Kawamura, T., Lake, D., Masuho, Y., Mitchell, W. M. & Hersh, E. M., 1990, In : Journal of Virology. 64, 11, p. 5301-5305 5 p.

Research output: Contribution to journalArticle

Immunodominant Epitopes
Virus Diseases
Human immunodeficiency virus 1
HIV-1
glycoproteins
8 Citations (Scopus)

Antibodies to tumor necrosis factor: a component of B cell immune responses with a role in tumor/host interaction

Barbuto, J. A. M., Grimes, W. J. & Hersh, E. M., Jan 1995, In : Cancer Immunology, Immunotherapy. 40, 1, p. 31-36 6 p.

Research output: Contribution to journalArticle

B-Lymphocytes
Tumor Necrosis Factor-alpha
Antibodies
Neoplasms
Antibody Formation
22 Citations (Scopus)

Antibody-dependent cell-mediated cytotoxicity in human cancer. Characterization of patient leukocyte activity and treatment effects

Hersh, E. M., Murphy, S. G., Gutterman, J. U., Morgan, J., Quesada, J., Zander, A. & Stewart, D., 1982, In : Cancer. 49, 2, p. 251-260 10 p.

Research output: Contribution to journalArticle

Antibody-Dependent Cell Cytotoxicity
Leukocytes
Neoplasms
Therapeutics
Erythrocytes
28 Citations (Scopus)

Antibody development to viral and allogeneic tumor cell-associated antigens in patients with malignant melanoma and ovarian carcinoma treated with lysates of virus-infected tumor cells

Savage, H. E., Rossen, R. D., Hersh, E. M., Freedman, R. S., Bowen, J. M. & Plager, C., 1986, In : Cancer Research. 46, 4 II, p. 2127-2133 7 p.

Research output: Contribution to journalArticle

Oncogenic Viruses
Melanoma
Carcinoma
Antigens
Viruses
9 Citations (Scopus)

Antibody responses of remission leukemia patients receiving active specific and nonspecific immunotherapy

Granatek, C. H., Ezaki, K., Hersh, E. M., Keating, M. J. & Rasmussen, S., 1981, In : Cancer. 47, 2, p. 272-279 8 p.

Research output: Contribution to journalArticle

Immunotherapy
Antibody Formation
Leukemia
Mycobacterium bovis
Antigens
26 Citations (Scopus)

Antigen dose in the human immune response. Dose-response relationships in the human immune response to Keyhole limpet hemocyanin

Curtis, J. E., Hersh, E. M., Butler, W. T. & Rossen, R. D., 1971, In : The Journal of Laboratory and Clinical Medicine. 78, 1, p. 61-69 9 p.

Research output: Contribution to journalArticle

Antigens
Immunization
Lymphocytes
Hemagglutinins
Skin
103 Citations (Scopus)

Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast

Coronella, J. A., Perry, C. S., Welch, M., Trevor, K. T., Stopeck, A. T., Villar, H. & Hersh, E. M., Aug 15 2002, In : Journal of Immunology. 169, 4, p. 1829-1836 8 p.

Research output: Contribution to journalArticle

Carcinoma, Ductal, Breast
B-Lymphocytes
Antigens
Neoplasms
Ductal Carcinoma
8 Citations (Scopus)

Antigen expression and cell surface properties of human leukemic blasts

Cotropia, J. P., Gutterman, J. U. & Hersh, E. M., 1976, In : Annals of the New York Academy of Sciences. Vol. 276, p. 146-164 19 p.

Research output: Contribution to journalArticle

Surface Properties
Surface properties
Immunoglobulin G
Immunoglobulin Fab Fragments
Antigens
49 Citations (Scopus)

Antigen solubilized from human leukemia: Lymphocyte stimulation

Gutterman, J. U., Mavligit, G., McCredie, K. B., Bodey, G. P., Freireich, E. J. & Hersh, E. M., 1972, In : Science. 177, 4054, p. 1114-1115 2 p.

Research output: Contribution to journalArticle

Lymphocyte Activation
Leukemia
Lymphocytes
Antigens
Tissue Donors
9 Citations (Scopus)

Antigen-specific immunity in recipients of leukocyte transfusions from immune donors.

Curtis, J. E., Hersh, E. M. & Freireich, E. J., Dec 1970, In : Cancer Research. 30, 12, p. 2921-2929 9 p.

Research output: Contribution to journalArticle

Maternally Acquired Immunity
Leukocyte Transfusion
Hemagglutination Tests
Antibody Specificity
Lymphocyte Activation
33 Citations (Scopus)

Antiproliferative and antitumor activity of the 2-cyanoaziridine compound imexon on tumor cell lines and fresh tumor cells in vitro

Hersh, E. M., Gschwind, C. R., Taylor, C. W., Dorr, R. T., Taetle, R. & Salmon, S. E., Aug 19 1992, In : Journal of the National Cancer Institute. 84, 16, p. 1238-1244 7 p.

Research output: Contribution to journalArticle

Tumor Cell Line
Tumors
Tumor
Cells
Line
42 Citations (Scopus)

Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes

Punt, C. J. A., Barbuto, J. A. M., Zhang, H., Grimes, W. J., Hatch, K. D. & Hersh, E. M., Jul 1994, In : Cancer Immunology, Immunotherapy. 38, 4, p. 225-232 8 p.

Research output: Contribution to journalArticle

Neoplasm Antibodies
Anti-Idiotypic Antibodies
B-Lymphocytes
Neoplasms
Feeder Cells
16 Citations (Scopus)

A phase 1-2 study of imexon plus dacarbazine in patients with unresectable metastatic melanoma

Weber, J. S., Samlowski, W. E., Gonzalez, R., Ribas, A., Stephenson, J., O'Day, S., Sato, T., Dorr, R. T., Grenier, K. & Hersh, E. M., Aug 1 2010, In : Cancer. 116, 15, p. 3683-3691 9 p.

Research output: Contribution to journalArticle

Dacarbazine
Melanoma
Maximum Tolerated Dose
Pharmacokinetics
Survival
85 Citations (Scopus)

A phase 2 clinical trial of nab-Paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma

Hersh, E. M., O'Day, S. J., Ribas, A., Samlowski, W. E., Gordon, M. S., Shechter, D. E., Clawson, A. A. & Gonzalez, R., Jan 1 2010, In : Cancer. 116, 1, p. 155-163 9 p.

Research output: Contribution to journalArticle

Melanoma
Clinical Trials
Drug Therapy
Survival
Albumin-Bound Paclitaxel
2 Citations (Scopus)

A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma

Cohen, S. J., Zalupski, M. M., Conkling, P., Nugent, F., Ma, W. W., Modiano, M., Pascual, R., Lee, F. C., Wong, L. & Hersh, E. M., Dec 24 2015, (Accepted/In press) In : American Journal of Clinical Oncology: Cancer Clinical Trials.

Research output: Contribution to journalArticle

gemcitabine
Multicenter Studies
Adenocarcinoma
Placebos
Drug Therapy
37 Citations (Scopus)

A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors

Taylor, C. W., Dorr, R. T., Fanta, P., Hersh, E. M. & Salmon, S. E., 2001, In : Cancer Chemotherapy and Pharmacology. 47, 1, p. 83-88 6 p.

Research output: Contribution to journalArticle

Pharmacodynamics
Asparaginase
Tumors
Asparagine
Neoplasms
208 Citations (Scopus)

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

Hersh, E. M., O'Day, S. J., Powderly, J., Khan, K. D., Pavlick, A. C., Cranmer, L. D., Samlowski, W. E., Nichol, G. M., Yellin, M. J. & Weber, J. S., Jun 2011, In : Investigational New Drugs. 29, 3, p. 489-498 10 p.

Research output: Contribution to journalArticle

Dacarbazine
Multicenter Studies
Melanoma
Drug Therapy
ipilimumab
31 Citations (Scopus)

A phase II trial of recombinant tumor necrosis factor in patients with adenocarcinoma of the pancreas: A southwest oncology group study

Brown, T. D., Goodman, P., Fleming, T., Macdonald, J. S., Hersh, E. M. & Braun, T. J., 1991, In : Journal of Immunotherapy. 10, 5, p. 376-378 3 p.

Research output: Contribution to journalArticle

Pancreas
Adenocarcinoma
Tumor Necrosis Factor-alpha
Hypertriglyceridemia
Anorexia
21 Citations (Scopus)

A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: A Southwest Oncology Group Study

Whitehead, R. P., Fleming, T., Macdonald, J. S., Goodman, P. J., Neefe, J., Braun, T. J., Swinnen, L. J. & Hersh, E. M., 1990, In : Journal of Biological Response Modifiers. 9, 6, p. 588-591 4 p.

Research output: Contribution to journalArticle

Adenocarcinoma
Tumor Necrosis Factor-alpha
Nausea
Vomiting
Subclavian Vein
18 Citations (Scopus)

A Phase II Trial of Vinorelbine Tartrate in Patients with Disseminated Malignant Melanoma and One Prior Systemic Therapy: A Southwest Oncology Group Study

Whitehead, R. P., Moon, J., McCachren, S. S., Hersh, E. M., Samlowski, W. E., Beck, J. T., Tchekmedyian, N. S. & Sondak, V. K., Apr 15 2004, In : Cancer. 100, 8, p. 1699-1704 6 p.

Research output: Contribution to journalArticle

Melanoma
Therapeutics
Confidence Intervals
vinorelbine
Disease-Free Survival
18 Citations (Scopus)

A phase i study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

Cohen, S. J., Zalupski, M. M., Modiano, M. R., Conkling, P., Patt, Y. Z., Davis, P., Dorr, R. T., Boytim, M. L. & Hersh, E. M., Jul 2010, In : Cancer Chemotherapy and Pharmacology. 66, 2, p. 287-294 8 p.

Research output: Contribution to journalArticle

gemcitabine
Pancreatic Neoplasms
Toxicity
Maximum Tolerated Dose
Abdominal Pain
5 Citations (Scopus)

A phase I study of intravenous azimexon therapy in human cancer

Patt, Y. Z., Hersh, E. M., Reuben, J., Claghorn, L. & Mavligit, G., 1986, In : Journal of Biological Response Modifiers. 5, 4, p. 313-318 6 p.

Research output: Contribution to journalArticle

Azirines
Aziridines
Immunologic Adjuvants
Drug Evaluation
Lymphocyte Activation
38 Citations (Scopus)

A phase I study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously daily for 5 consecutive days every 3 weeks in patients with advanced solid tumors

Ebbinghaus, S., Rubin, E., Hersh, E. M., Cranmer, L. D., Bonate, P. L., Fram, R. J., Jekunen, A., Weitman, S. & Hammond, L. A., Nov 1 2005, In : Clinical Cancer Research. 11, 21, p. 7807-7816 10 p.

Research output: Contribution to journalArticle

Maximum Tolerated Dose
Neoplasms
Neutropenia
Fatigue
Melanoma
18 Citations (Scopus)
Granulocyte-Macrophage Colony-Stimulating Factor
Bone
Granulocytes
Eructation
Bone Marrow